Zum Inhalt

1997

 

 

 

Baghestanian M, Hofbauer R, Kress HG, Wojta J, Fabry A, Binder BR, Kaun C, Muller MR, Mehrabi MR, Kapiotis S, Sengoelge G, Ghannadan M, Lechner K, Valent P. Thrombin augments vascular cell-dependent migration of human mast cells: role of MGF. Thromb Haemost. 1997, Vol. 77(3), p577-584.

Carroll VA, Griffiths MR, Geiger M, Merlo C, Furlan M, Lammle B, Binder BR. Plasma protein C inhibitor is elevated in survivors of myocardial infarction. Arterioscler Thromb Vasc Biol. 1997, Vol. 17(1), p114-118.

Christ G, Hufnagl P, Kaun C, Mundigler G, Laufer G, Huber K, Wojta J, Binder BR. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.  Arterioscler Thromb Vasc Biol. 1997, Vol. 17(4), p723-730.

de Martin R, Raidl M, Hofer E, Binder BR. Adenovirus-mediated expression of green fluorescent protein.  Gene Ther. 1997, Vol. 4(5), p493-495.

Ecke S, Geiger M, Binder BR. Heparin binding of protein-C inhibitor-analysis of the effect of heparin on the interaction of protein-C inhibitor with tissue kallikrein.  Eur J Biochem. 1997, Vol. 248(2), p475-480.

 

Ebel T, Middleton FS, Frisch A, Lipp J. Characterization of a secretory Type Theileria parva Glutaredoxin Homologue identified by novel screening procedure.  J Biol Chem. 1997, Vol. 272(5), p3042-3048.

 

Geiger M, Krebs M, Jerabek I, Binder BR. Protein C inhibitor (PCI) and heparin cofactor II (HCII): possible alternative roles of these heparin-binding serpins outside the hemostatic system.  Immunopharmacology, 1997, Vol. 36(2-3), p279-284.

 

Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR. Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598.  J Biol Chem. 1997, Vol. 272(45), p28563-28567.

 

Schmid A, Billich A. Simpe method for high sensitivy Chemiluminescence ELISA using conventional Laboratory equipment.  BioTechniques 1997, Vol. 22(2), p278-280.

 

Sillaber C, Baghestanian M, Hofbauer R, Virgolini I, Bankl HC, Fureder W, Agis H, Willheim M, Leimer M, Scheiner O, Binder BR, Kiener HP, Bevec D, Fritsch G, Majdic O, Kress HG, Gadner H, Lechner K, Valent P. Molecular and functional characterization of the urokinase receptor on human mast cells.  J Biol Chem. 1997, Vol. 272(12), p7824-7832.

 

Stegnar M, Peternel P, Uhrin P, CvelbarMarinko T, GorsicTomazic K, Binder BR. Fibrinolysis in patients with the 1691 G->A mutation in factor V gene and history of deep vein thrombosis.  Fibrinolysis and Proteolysis, 1997, Vol. 11(4), p201-207.

 

Tsuchiya H, Sunayama C, Okada G, Matsuda E, Tomita K, Binder BR. Plasminogen activator inhibitor-1 accelerates lung metastasis formation of human fibrosarcoma cells.  Anticancer Res.1997, Vol. 17(1A), p313-316.

 

Tschugguel W, Zhegu Z, Schneeberger C, Tantscher E, Czerwneka K, Fabry A, Wojta J, Zeillinger R, Huber JC. Estrogen does not induce the Calcium-dependent Nitric Oxide synthase in cultured Human Uterine Endothelial and Myometrial Smooth Muscle Cells   J Vasc Res, 1997, Vol. 34 p281-288.

 

Zechmeister-Machhart M, Hufnagl P, Uhrin P, Korschineck I, Binder BR, Geiger M. Molecular cloning and sequence analysis of the mouse protein C inhibitor gene.  Gene, 1997, Vol. 186(1), p61-66.

 

Uchiba M, Okajima K, Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: Novel Biological activity of AT III.  Sem in Thromb Hemost 1997, Vol. 23 p583-590.

 

Zehetgruber M, Beckmann R, Gabriel H, Christ G, Binder BR, Huber K. Comparative cross-over study of the effects of lisinopril and doxazosin on insulin, glucose and lipoprotein metabolism and the endogenous fibrinolytic system.  Fibrinolysis and Proteolysis, 1997, Vol. 11 Suppl. 2, p153-158.

 

Zhang WJ, Wojta J, Binder BR. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression.  J Vasc Res. 1997, Vol. 34(4), p273-280.

 

Zhang WJ, Wojta J, Binder BR. Effect of Notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cells of human pulmonary artery.  Cell Mol Biol 1997, Vol. 43(4) p581-587.

 

Zhang WJ, Bammer T, Binder BR, Wojta J. Effect of endothelin on the regulation of the fibrinolytic system of cultured human vascular smooth muscle cells.  Fibrinolysis and Proteolysis, 1997, Vol. 11(5-6), p245-250.

 

Zhang WJ, Wojta J, Binder BR. Notoginsenoside R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice in vivo. Arterioscler Thromb Vasc Biol. 1997, Vol. 17(3), p465-474.